PAN3 and familial pancreatic carcinoma: Ping et al. found that PAN3-AS1 was one of the ferroptosis-related lncRNAs that were responsible for patients’ prognosis and that PAN3-AS1 could be a possible therapeutic target for pancreatic cancer.